Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions. 

 

View bio business grants awarded by year.
Amir Naqwi
Amir Naqwi, PhD
Airway Cell Delivery with Visualization
We are proposing the development of an airway cell sprayer that would be included in the instrument channel of a bronchoscope for depositing viable…
2020-2021
Maria Athanasiou
Maria Athanasiou, PhD
Regenerative Medicine for the Durable Remission of HIV
Building on successful primate model studies, MarPam Pharma is developing a one‐time treatment for durable remission of HIV in the absence of…
2020-2021
image of Patrick Walsh
Patrick Walsh, MS
Extending the Anatomi Corp differentiation ecosystem for the production of hiPSC derived neuronal subtypes
The goal of this grant is to bring Anatomi Corp's Chrono™ Platform to market. A small portion of this funding will offset overhead costs associated…
2019-2020
image of Neil Otto, PhD
Neil Otto, PhD
Amaxa LV Unit for engineered therapeutic cells for regenerative medicine
The ultimate goal is to provide our gene transfer transposon/transposase platforms to the rapidly growing field of gene modified cell therapy. B‐…
2019-2020
Timothy O'Brien, DVM, PhD
Development of organoid-derived chondrocyte products for articular cartilage repair
We have developed a novel technology that induces human stem cells to form cartilage. In this project we aim to take the first steps in developing…
2019-2020
image of Richard Murphy, General Manager
Richard Murphy, General Manager
Development of regenerative engineered tissue embedded cardiovascular device
The aim of this grant proposal is to develop cardiovascular devices at Vascudyne with regenerative engineered tissue technology licensed from the…
2019-2020
image of Ohad Gafni, PhD
Ohad Gafni, PhD
Human hematopoiesis in genetically modified swine
Our goal is to engineer a humanized swine model that carries key human cytokines, this strategy will provide the immunology field a high capacity…
2019-2020
image of Dominique Davidow, PhD
Dominique Davidow, PhD
Automation of cell culture with a Terumo Quantum Cell Expansion System to create recellularized bioengineered whole organs
Perfusion decellularization and recellularization are patented technologies owned by Miromatrix Medical Inc. Upon complete removal of cellular…
2019-2020
image of Frank H. Burton, PhD
Frank H. Burton, PhD
Therapeutic & IP optimization of provisionally-patented anti-inflammatory wound healing-accelerant
This project is performing translational studies on a wound-healing accelerant that has been provisionally patented. Animal studies showed that…
2019-2020
image of Vanesa Alonso-Camino, PhD
Vanesa Alonso-Camino, PhD
Development of technolgy for the large-scale production of a novel dendritic cell vaccine for the treatment of glioblastoma
We plan to isolate and expand glioblastoma (GBM) cells from commercially available fresh tumor tissue. These cells will be used to create tumor…
2019-2020
Timothy D. O'Brien, DVM, PhD
Timothy D. O'Brien, DVM, PhD
Development of a Cellular Therapy for Parkinson's Disease
Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.  In the present proposal we will evaluate critical…
2018-2019
image of Joseph S. Uzarski, PhD
Joseph S. Uzarski, PhD
Development of a Perfusion-Based Testing System to Evaluate Short-Term Function in Bioengineered Kidney Grafts
Miromatrix is working to create a new source of kidney grafts for thousands of patients suffering from kidney failure who are wait-listed for…
2018-2019